JAMA Network

Interview with Sharmili Edwin Thanarajah, MD, author of Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations. Hosted by John Torous, MD. Related Content: Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain

In this engaging discussion, Dr. Sammy Saab, a leading expert in liver disease from UCLA, shares insights on MASLD and MASH in the U.S. Hispanic/Latino population. He reveals the 'perfect storm' of factors affecting this group, from genetics to access to healthcare. Dr. Saab addresses critical gaps in primary care and discusses innovative screening methods. He emphasizes the importance of culturally sensitive diet guidance and practical lifestyle interventions, advocating for tailored solutions to improve health outcomes.

Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Interview with Nicholas G. Murray, PhD, author of Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players. Hosted by Neil Bressler, MD. Related Content: Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players

Interview with Tyson S. Barrett, PhD, and George M. Eid, MD, authors of Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists. Hosted by Jamie Coleman, MD. Related Content: Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists

Interview with Lee Wheless, MD, PhD, author of Nicotinamide for Skin Cancer Chemoprevention. Hosted by Adewole S. Adamson, MD. Related Content: Nicotinamide for Skin Cancer Chemoprevention (Original Investigation) Nicotinamide for Skin Cancer Chemoprevention (Editorial)

Join Gregory Curfman, JAMA Executive Editor, and Robert O. Bonow, JAMA Cardiology Editor, as they delve into groundbreaking research from the European Society of Cardiology Congress. They discuss the rise of remote monitoring for detecting asymptomatic atrial fibrillation, the benefits of semaglutide and tirzepatide for heart failure, and findings that show improved outcomes from complete revascularization in myocardial infarction. They also highlight important vaccination insights and the ongoing challenges of women’s participation in cardiovascular research.

Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD. Related Content: Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

Interview with David C. Whiteman, MBBS, PhD, author of A Risk Prediction Tool for Invasive Melanoma. Hosted by Adewole S. Adamson, MD. Related Content: A Risk Prediction Tool for Invasive Melanoma

Azelastine nasal spray shows promise as a preventive treatment for COVID-19, according to a study involving nearly 600 participants. The experts discuss its significant reductions in infection rates and potential benefits against other respiratory viruses. A phase two study points to its efficacy as an antiviral treatment, though the need for larger trials is emphasized. The episode highlights its mechanisms and implications for at-risk populations, underscoring a hopeful advance in public health measures.